Comparison of C-methionine PET and F-fluorodeoxyglucose PET in differentiated thyroid cancer

Nuclear Medicine Communications

Volumn 29, Issue 8, 2008, Pages 711-716

  Phan, Ha T T ^a   Jager, Pieter L ^a   Plukker, John T M ^a   Wolffenbuttel, Bruce H R ^b   Dierckx, Rudi A ^b   Links, Thera P ^b  

^a Departments of Nuclear Medicine and Molecular Imaging   (Netherlands)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Amino acids; Differentiated thyroid cancer; Positron emission tomography

Indexed keywords

CARBON; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; METHIONINE; RADIOPHARMACEUTICAL AGENT; THYROGLOBULIN; AMINO ACID; IODINE 131; METHIONINE C 11; TRACER;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; SCINTISCANNING; THYROID TUMOR; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DRUG ACCUMULATION; DRUG UPTAKE; FOLLOW UP; IMAGE ANALYSIS; ISOTOPE LABELING; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; STATISTICAL ANALYSIS; THYROID CANCER; ULTRASOUND; WHOLE BODY SCINTISCANNING;

ADULT; AGED; CARBON RADIOISOTOPES; FEASIBILITY STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; METHIONINE; MIDDLE AGED; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; THYROGLOBULIN; THYROID NEOPLASMS;

EID: 55249085388     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328301835c     Document Type: Article

References (35)

1. Sherman SI. Thyroid carcinoma. Lancet 2003; 36:501-511.
2. Ringel MD, Ladenson PW. Controversies in the follow-up and management of well-differentiated thyroid cancer. Endocr Relat Cancer 2004; 11:97-116.
3. Khan N, Oriuchi N, Higuchi T, Zhang H, Endo K. PET in the follow-up of differentiated thyroid cancer. Br J Radiol 2003; 76:690-695.
4. Schoder H, Yeung WD. Positron emission imaging of head and neck cancer, including thyroid carcinoma. Sem Nucl Med 2004; 34:180-197.
5. Stokkel MP, Duchateau CS, Dragoiescu C. The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature. Q J Nucl Med Mol Imaging 2006; 50:78-87.
6. Jager PL, Vaalburg W, Pruim J, de Vries EGE, Langen KJL, Piers DA. Radiolabled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001; 3:432-445.
7. Becherer A, Karanikas G, Szabo M, Zettinig G, Asenbaum S, Marosi C, et al. Brain tumor imaging with PET: a comparision between (18F)fluorodopa and (11C)methionine. Eur J Nucl Med Mol Imaging 2003; 30:1561-1567.
8. Zhang H, Yoshikawa K, Tamura K, Sagou K, Tian M, Suhara T, et al. Carbon-11-methionine positron emission tomography imaging of chordoma. Skeletal Radiol 2004; 33:524-530.
9. Sasaki M, Kuwabara Y, Yoshida T, Nakagawa M, Koga H, Hayashi K, et al. Comparison of MET-PET and FDG-PET for differentiation between benign lesions and malignant tumors of the lung. Ann Nucl Med 2001; 15:425-431.
10. Wieder H, Ott K, Zimmermann F, Nekarda H, Stolluss J, Watzlowik P, et al. PET imaging with [11C] methyl-L-methionine for therapy monitoring in patients with rectal cancer. Eur J Nucl Med Mol Imaging 2002; 29:789-796.
11. Isselbacher KJ. Sugar and amino acid transport by cells in culture--differences between normal and malignant cells. N Engl J Med 1972; 286:929-933.
12. Busch H, Davis JR, Honing GR, Anderson DC, Nair PV, Nyhan WL. The uptake of a variety of amino acids into nuclear proteins of tumors and other tissues. Cancer Res 1959; 19:1030-1039.
13. Saier MH Jr, Daniels GA, Boerner P, Lin J. Neutral amino acid transport systems in animal cells: potential targets of oncogene action and regulators of cellular growth. J Membr Biol 1988; 104:1-20.
14. Chung JK, Kim YK, Kim S, Lee YJ, Paek S, Yeo JS, et al. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. Eur J Nucl Med 2002; 29:176-182.
15. Ho CL. Clinical PET imaging- an Asian perspective. Ann Acad Med Singapore 2004; 33:155-165.
16. Inoue T, Kim EE, Wong FCL, Yang DJ, Bassa P, Wong WH, et al. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors. J Nucl Med 1996; 37:1472-1476.
17. Minn H, Clavo AC, Greman R, Wahl RL. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 1995; 36:252-258.
18. Kubota R, Kubota K, Yamada S, Tada M, Takahashi T, Iwata R, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995; 36:484-492.
19. Kubota R, Kubota K, Yamada S, Tada S, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med 1994; 35:104-112.
20. Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27:235-238.
21. Warburg O. The metabolism of tumors. New York: Richard R. Smit; 1931. pp. 129-169.
22. Kubota A, Yamada S, Kubota R, Ishiwata K, Tamahashi N, Ido T. Intramural distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972-1980.
23. Strauss LG. Fluorine-18-deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996; 23:1409-1415.
24. van Tol KM, Jager PL, Piers DA, Pruim J, de Vries EG, Dullaart RP, et al. Better yield of (18)fluorodeoxyglucose-positron emission tomography in patients with metastatic differentiated thyroid carcinoma during thyrotropin stimulation. Thyroid 2002; 12:381-387.
25. Moog F, Linke R, Manthey N, Tiling R, Knesewitsch P, Tatsch K, et al. Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma. J Nucl Med 2000; 41:1989-1995.
26. Petrich T, Börner AR, Otto D, Hofmann M, Knapp WH. Influence of rhTSH on [(18)F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging 2002; 29:641-647.
27. Chin BB, Patel P, Cohade C, Ewertz M, Wahl R, Ladenson P. Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma. J Clin Endocrinol Metab 2004; 89:91-95.
28. 18F]fluoroethyl)-L-tyrosine. Nucl Med Biol 2007; 34:305-314.
29. Joensuu H, Ahonen A. Imaging of metastases of thyroid carcinoma with fluorine-18-fluorodeoxyglucose. J Nucl Med 1987; 28:910-914.
30. Grünwald F, Menzel C, Bender H, Palmedo H, Willkomm P, Ruhlmann J, et al. Comparison of 18FDG-PET with 131iodine and 99mTc-sestamibi scintigraphy in differentiated thyroid cancer. Thyroid 1997; 7:327-335.
31. Schluter B, Bohuslavizki KH, Beyer W, Plotkin M, Buchert R, Clausen M. Impact of FDG PET on patients with well differentiated thyroid cancer who present with elevated thyroglobulin and negative I-131 scan. J Nucl Med 2001; 42:71-76.
32. Rubello D, Fanti S, Nanni C, Farsad M, Castellucci P, Boschi S, et al. 11C-methionine PET/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis. Eur J Nucl Med Mol Imaging 2006; 33:453-459.
33. Beggs AD, Hains SF. Localization of parathyroid adenomas using 11C-methionine positron emission tomography. Nucl Med Commun 2005; 26:133-136.
34. Sundin A, Johansson C, Hellman P, Bergström M, Ahlström H, Jacobsen GB, et al. PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism. J Nucl Med 1996; 37:1766-1770.
35. Melon P, Luxen A, Hamoir E, Meurisse M. Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism. Eur J Nucl Med 1995; 22:556-558.